Derleme

Scabies: Clinical Signs, Diagnosis and Current Treatment

Cilt: 4 Sayı: 2 31 Mayıs 2023
PDF İndir
EN

Scabies: Clinical Signs, Diagnosis and Current Treatment

Abstract

Scabies is a parasitic disease caused by Sarcoptes scabiei var hominis. It can spread through indirect contact with contaminated objects as well as direct skin-to-skin contact. Widespread itching that gets worse at night can be present along with a variety of lesions, including papules, vesicles, nodules and excoriations. Mites, eggs, or faeces should be visualised using an additional tool for a definitive diagnosis. Only the patient's history and physical examination are used to diagnose clinical scabies or suspected clinical scabies. It is included in the differential diagnosis with other itchy skin diseases. Although other topical treatments like benzyl benzoate, sulphur, and lindane are available, permethrin is still the top option. Oral ivermectin is used as an efficient, secure, and affordable treatment for scabies in many countries despite not having FDA approval for this use. Current search for treatment continues, and there are studies on moxidectin and isoxazoline derivative drugs. Application errors, skipping treatment repetitions, inadequate environmental cleaning, not receiving treatment from the patient's relatives, and not providing the patient with the necessary precautions in writing are all reasons why treatments fail. It is known that good results can be obtained in the treatment of scabies, which continues to be a global public health problem, if physicians have sufficient knowledge and can manage their patients appropriately. By summarising the information that is currently available, this review aims to provide an update on the clinical characteristics, diagnosis, treatment, and management of scabies.

Keywords

scabies , treatment , diagnosis

Kaynakça

  1. Lluch Galcerá J, Carrascosa Carrillo J, Boada García A. Epidemic Scabies: New Treatment Challenges in an Ancient Disease. Actas Dermosifiliogr 2022.
  2. Widaty S, Miranda E, Cornain EF, Rizky LA. Scabies: update on treatment and efforts for prevention and control in highly endemic settings. J Infect Dev Ctries. 2022;16(2):244–51.
  3. Arlian LG, Morgan MS. A review of Sarcoptes scabiei: Past, present and future. Parasites and Vectors. 2017;10(1):1–22.
  4. Currie BJ, McCarthy JS. Permethrin and Ivermectin for Scabies. N Engl J Med. 2010;362(8):717–25.
  5. Thomas C, Coates SJ, Engelman D, Chosidow O, Chang AY. Ectoparasites: Scabies. J Am Acad Dermatol [Internet]. 2020;82(3):533–48.
  6. Salavastru CM, Chosidow O, Boffa MJ, Janier M, Tiplica GS. European guideline for the management of scabies. J Eur Acad Dermatology Venereol. 2017;31(8):1248–53.
  7. Arora P, Rudnicka L, Sar-Pomian M, Wollina U, Jafferany M, Lotti T, et al. Scabies: A comprehensive review and current perspectives. Vol. 33, Dermatologic Therapy. 2020.
  8. Sunderkötter C, Wohlrab J, Hamm H. Epidemiologie, Diagnostik und Therapie der Skabies. Dtsch Arztebl Int. 2021;118(41):695–704.
  9. Leung AKC, Lam JM, Leong KF. Scabies: A Neglected Global Disease. Curr Pediatr Rev. 2019;16(1):33–42.
  10. Chosidow O, Ph D. Scabies. new Engl J o f Med. 2006.

Kaynak Göster

APA
Koç, H. A., & Ünlü Açıkel, S. (2023). Scabies: Clinical Signs, Diagnosis and Current Treatment. Archives of Current Medical Research, 4(2), 62-69. https://doi.org/10.47482/acmr.1244299